Blood culture procedures and practices in the neonatal intensive care unit: A survey of a large multicenter collaborative in California.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
10 2023
Historique:
medline: 23 10 2023
pubmed: 17 3 2023
entrez: 16 3 2023
Statut: ppublish

Résumé

To describe variation in blood culture practices in the neonatal intensive care unit (NICU). Survey of neonatal practitioners involved with blood culturing and NICU-level policy development. We included 28 NICUs in a large antimicrobial stewardship quality improvement program through the California Perinatal Quality Care Collaborative. Web-based survey of bedside blood culture practices and NICU- and laboratory-level practices. We evaluated adherence to recommended practices. Most NICUs did not have a procedural competency (54%), did not document the sample volume (75%), did not receive a culture contamination report (57%), and/or did not require reporting to the provider if <1 mL blood was obtained (64%). The skin asepsis procedure varied across NICUs. Only 71% had a written procedure, but ≥86% changed the needle and disinfected the bottle top prior to inoculation. More than one-fifth of NICUs draw a culture from an intravascular device only (if present). Of 13 modifiable practices related to culture and contamination, NICUs with nurse practitioners more frequently adopted >50% of practices, compared to units without (92% vs 50% of units; P < .02). In the NICU setting, recommended practices for blood culturing were not routinely performed.

Identifiants

pubmed: 36924050
pii: S0899823X23000338
doi: 10.1017/ice.2023.33
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1576-1581

Subventions

Organisme : AHRQ HHS
ID : R18 HS026168
Pays : United States

Auteurs

Linda Lefrak (L)

Nurse Consultant, State of California Department of Public Health, Center for Health Care Quality, Healthcare-Associated Infections Program, Sacramento, California.

Kristen E Schaffer (KE)

California Perinatal Quality Care Collaborative, Palo Alto, California.
Division of Neonatology, Stanford University, Palo Alto, California.

Janine Bohnert (J)

California Perinatal Quality Care Collaborative, Palo Alto, California.
Division of Neonatology, Stanford University, Palo Alto, California.

Peter Mendel (P)

RAND Corporation, Santa Monica, California.

Kurlen S E Payton (KSE)

California Perinatal Quality Care Collaborative, Palo Alto, California.
Division of Neonatology, Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California.

Henry C Lee (HC)

California Perinatal Quality Care Collaborative, Palo Alto, California.
Division of Neonatology, Stanford University, Palo Alto, California.

Michael A Bolaris (MA)

Department of Pediatrics, Rancho Los Amigos Rehabilitation Center, Downey, California.

Kenneth M Zangwill (KM)

Division of Pediatric Infectious Diseases, Department of Infection Prevention and Control, Harbor-UCLA Medical Center and The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH